Genetic Variations and Haplotype Structures of the ABC Transporter Gene ABCC1 in a Japanese Population

  • FUKUSHIMA-UESAKA Hiromi
    Project Team for Pharmacogenetics, National Institute of Health Sciences
  • SAITO Yoshiro
    Project Team for Pharmacogenetics, National Institute of Health Sciences Division of Biochemistry and Immunochemistry, National Institute of Health Sciences
  • TOHKIN Masahiro
    Project Team for Pharmacogenetics, National Institute of Health Sciences Division of Medicinal Safety Science, National Institute of Health Sciences
  • MAEKAWA Keiko
    Project Team for Pharmacogenetics, National Institute of Health Sciences Division of Biochemistry and Immunochemistry, National Institute of Health Sciences
  • HASEGAWA Ryuichi
    Division of Medicinal Safety Science, National Institute of Health Sciences
  • KAWAMOTO Manabu
    Division of Genomic Medicine, Department of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University
  • KAMATANI Naoyuki
    Division of Genomic Medicine, Department of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University
  • SUZUKI Kazuko
    Nerima General Hospital
  • YANAGAWA Tatsuo
    Nerima General Hospital
  • KAJIO Hiroshi
    Division of Endocrine and Metabolic Diseases, the Hospital, Research Institute, International Medical Center of Japan
  • KUZUYA Nobuaki
    Division of Endocrine and Metabolic Diseases, the Hospital, Research Institute, International Medical Center of Japan
  • YASUDA Kazuki
    Department of Metabolic Disorder, Research Institute, International Medical Center of Japan
  • SAWADA Jun-ichi
    Project Team for Pharmacogenetics, National Institute of Health Sciences Division of Biochemistry and Immunochemistry, National Institute of Health Sciences

この論文をさがす

抄録

  Multidrug resistance-related protein 1 (MRP1), an ATP-binding cassette transporter encoded by the ABCC1 gene, is expressed in many tissues, and functions as an efflux transporter for glutathione-, glucuronate- and sulfate-conjugates as well as unconjugated substrates. In this study, the 31 exons and their flanking introns of ABCC1 were comprehensively screened for genetic variations in 153 Japanese subjects to elucidate the linkage disequilibrium (LD) profiles and haplotype structures of ABCC1 that is necessary for pharmacogenetic studies of the substrate drugs. Eighty-six genetic variations including 31 novel ones were found: 1 in the 5′-flanking region, 1 in the 5′-untranslated region (UTR), 20 in the coding exons (9 synonymous and 11 nonsynonymous variations), 4 in the 3′-UTR, and 60 in the introns. Of these, eight novel nonsynonymous variations, 726G>T (Trp242Cys), 1199T>C (Ile400Thr), 1967G>C (Ser656Thr), 2530G>A (Gly844Ser), 3490G>A (Val1164Ile), 3550G>A (Glu1184Lys), 3901C>T (Arg1301Cys), and 4502A>G (Asp1501Gly), were detected with an allele frequency of 0.003. Based on the LD profiles, the analyzed regions of the gene were divided into five LD blocks (Blocks -1 and 1 to 4). The multiallelic repeat polymorphism in the 5′-UTR was defined as Block -1. For Blocks 1, 2, 3 and 4, 32, 23, 23 and 13 haplotypes were inferred, and 9, 7, 7 and 6 haplotypes commonly found on ≥10 chromosomes accounted for ≥91% of the inferred haplotypes in each block. Haplotype-tagging single nucleotide polymorphisms for each block were identified to capture the common haplotypes. This study would provide fundamental and useful information for the pharmacogenetic studies of MRP1-dependently effluxed drugs in Japanese.<br>

収録刊行物

参考文献 (43)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ